DIAB ALMHANA: Open Payments
NPI 1619053477 · AVON LAKE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$167,782 in 459 payments from 21 companies in 2025. Trend: 2023 $83,932 · 2024 $72,053 · 2025 $167,782
Speaker / faculty: $119,007Honoraria: $29,425Travel & lodging: $7,433Food & beverage: $7,389Consulting: $4,440Education: $87
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 85 | $62,571 |
| ABBVIE INC. | 101 | $50,323 |
| Axsome Therapeutics, Inc. | 73 | $32,256 |
| Vanda Pharmaceuticals Inc. | 36 | $10,736 |
| Otsuka America Pharmaceutical, Inc. | 20 | $9,868 |
| Lundbeck LLC | 21 | $307 |
| Alkermes, Inc. | 11 | $226 |
| Supernus Pharmaceuticals, Inc. | 14 | $199 |
| Collegium Pharmaceutical, Inc. | 15 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $179 |
Products named: CAPLYTA, VRAYLAR, Auvelity, FANAPT, REXULTI, Qelbree, Jornay PM, HETLIOZ.
Industry payments across OH — which companies pay providers there.
